North America Infertility Testing And Treatment Market Forecast 2018-2026

Publisher Name :
Date: 29-Jan-2018
No. of pages: 85

Key Findings

The North America infertility testing and treatment market collected a net revenue of $6099.20 million in 2017. Over the forecasted period of 2018-2026, the market is expected to exhibit a CAGR of 6.07%, collecting a net total of $10326.86 million.

Market Insights

The North American region witnessed about 17% infertility cases due to male factors; while female factors were responsible only in 12% cases. However, rising use of contraceptive drugs is increasing infertility among the North American women. The U.S is the biggest market for infertility testing and treatment in this region, followed by Canada. It is estimated that up to 20% couples in Canada experience infertility to some extent. However, the cost of these infertility treatments varies across both these regions.

Competitive Insights

Progyny, Quest Diagnostic, Agilent, Illumina Inc, Andrology Solutions, Thermo Fisher Scientific Inc, Endo Pharmaceuticals, Elucigene, Natera Inc, Esco Micro Pte. Ltd, Ferring Pharmaceuticals, Vitrolife Ab, Integrated Genetics and, Roche are the noted companies in this market.

North America Infertility Testing And Treatment Market Forecast 2018-2026

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Ivf Dominates The Female Treatment Market
3.2.2. Oxidative Stress Analysis Is The Fastest Growing Male Infertility Testing Market
4. Market Overview
4.1. Market Definition
4.2. Market Drivers And Impact
4.2.1. Rise In Infertility And Treatment Awareness
4.2.2. Medical Tourism In Fertility Treatments
4.2.3. Surrogacy Laws Are Getting More Defined
4.2.4. Healthcare Advances Have Finetuned Fertility Treatment
4.2.5. Increasing Effectiveness of Treatments
4.2.6. Healthier Donor Eggs
4.2.7. Introduction of New Testing Devices
4.3. Restraints And Impact
4.3.1. Treatment Procedure Out of Reach To Many Due To Costs Involved
4.3.2. Country-Wise Regulatory Issues
4.4. Market Opportunities
4.4.1. Reducing The Cost of Treatment To Make It More Accessible
4.4.2. Ivf Attracting Investments From Private Equity Investors
4.4.3. Diy Testing Increasing Access And Reducing Cost
4.5. Market Challenges
4.5.1. Infertility Considered A Social Taboo Amongst Men
4.5.2. Perils of Multiple Pregnancies
4.5.3. Traditional Treatments Used Widely As An Alternative To Infertility Treatments
4.5.3.1. Diet And Supplements
4.5.3.2. Acupuncture
4.5.3.3. Therapy
4.5.3.4. Qigong
5. Infertility Causes
5.1. Causes of Male Infertility
5.1.1. Abnormality In The Sperm
5.1.2. Environmental Factors
5.1.3. Poor Health And Lifestyle
5.2. Causes of Female Infertility
5.2.1. Ovulation Disorders
5.2.2. Damage To Fallopian Tubes
5.3. Moral Questions
6. Male Infertility Testing And Treatment Market 2018-2026 ($ Million)
6.1. Market By Male Infertility Testing
6.1.1. Dna Fragmentation
6.1.2. Oxidative Stress Analysis
6.1.3. Sperm Penetration Assay
6.1.4. Computer Assisted Semen Analysis (Casa)
6.1.5. Sperm Agglutination
6.1.6. Microscopic Examination
6.1.7. Others
6.2. Market By Male Infertility Treatment
6.2.1. Vasovasostomy And Vasoepididymostomy (Vasectomy Reversal)
6.2.2. Sperm Retrieval Treatment
6.2.3. Microsurgical Sperm Aspiration (Mesa)
6.2.4. Testicular Sperm Extraction (Tese)
6.2.5. Varicocele Repairs
6.2.6. Assisted Reproductive Techniques (Art)
6.2.7. Intrauterine Insemination (Iui)
6.2.8. In Vitro Fertilization (Ivf)
6.2.9. Intracytoplasmic Sperm Injection (Icsi)
7. Female Infertility Testing And Treatment Market 2018-2026 ($ Million)
7.1. Market By Female Infertility Testing
7.1.1. Ovulation Testing
7.1.2. Hysterosalpingography
7.1.3. Laparoscopy
7.1.4. Transvaginal Ultrasound
7.1.5. Ovarian Reserve Testing
7.1.6. Hormonal Level Testing
7.1.7. Others (Genetic Testing)
7.2. Market By Female Infertility Treatment
7.2.1. In Vitro Fertilization
7.2.2. Intrauterine Insemination (Iui)
7.2.3. Drug And Hormone Therapies
8. North America Infertility Testing And Treatment Market By End-Users 2018-2026 ($ Million)
8.1. Fertility And Surgical Centers
8.2. Hospitals And Research Laboratories
8.3. Cryobanks
9. Key Analytics
9.1. Porters 5 Force Model
9.1.1. Threat of New Entrants
9.1.2. Threat of Substitute Products
9.1.3. Bargaining Power of Buyers
9.1.4. Bargaining Power of Suppliers
9.1.5. Intensity of Competitive Rivalry
9.2. Value Chain Analysis
9.2.1. Raw Material Procurement
9.2.2. Manufacturing
9.2.3. Supply Logistics
9.2.4. Distribution Channels
9.2.5. End Users
9.3. Key Buying Criteria
9.3.1. Treatment Options
9.3.2. Quality of Medical Procedures
9.3.3. Price of Treatments
9.3.4. Shift Towards Medical Tourism
9.3.5. Reimbursement
9.4. Regulatory Framework
9.5. Key Trends
9.5.1. Male Infertility Treatment Segment Is Rising
9.5.2. Fertility Tourism- An Important Trend
9.5.3. Upper Middle Income Group Is The Key Target
9.5.4. Regulatory Environment Key Market Enabler
9.5.5. More Couples Opting For Surrogacy
9.5.6. Technology Enabling The Success of Fertility Treatments
9.6. Vendor Landscape
9.7. Opportunity Matrix
10. Key Analytics - Testing Market
10.1. Porters 5 Force Analysis
10.1.1. Threat of New Entrants
10.1.2. Threat of Substitute Products
10.1.3. Bargaining Power of Buyers
10.1.4. Bargaining Power of Suppliers
10.1.5. Intensity of Competitive Rivalry
10.2. Key Buying Criteria
10.3. Vendor Landscape
10.4. Opportunity Matrix
11. North America Infertility Testing And Treatment Market Country Analysis 2018-2026 ($ Million)
11.1. Us
11.2. Canada
12. Competitive Analysis
12.1. Andrology Solutions
12.1.1. Overview
12.1.2. Product Portfolio
12.1.3. Scot Analysis
12.2. Endo Pharmaceuticals
12.2.1. Overview
12.2.2. Product Portfolio
12.2.3. Strategic Moves
12.2.4. Scot Analysis
12.3. Progyny
12.3.1. Overview
12.3.2. Product Portfolio
12.3.3. Strategic Moves
12.3.4. Scot Analysis
12.4. Ferring Pharmaceuticals
12.4.1. Overview
12.4.2. Product Portfolio
12.4.3. Strategic Moves
12.4.4. Scot Analysis
12.5. Genea
12.5.1. Overview
12.5.2. Product Portfolio
12.5.3. Strategic Moves
12.5.4. Scot Analysis
12.6. Halotech Dna
12.6.1. Overview
12.6.2. Product Portfolio
12.6.3. Strategic Moves
12.6.4. Scot Analysis
12.7. Irvine Scientific
12.7.1. Overview
12.7.2. Product Portfolio
12.7.3. Strategic Moves
12.7.4. Scot Analysis
12.8. Merck
12.8.1. Overview
12.8.2. Product Portfolio
12.8.3. Strategic Moves
12.8.4. Scot Analysis
12.9. Origio
12.9.1. Overview
12.9.2. Product Portfolio
12.9.3. Strategic Moves
12.9.4. Scot Analysis
12.10. Ovascience
12.10.1. Overview
12.10.2. Product Portfolio
12.10.3. Strategic Moves
12.10.4. Scot Analysis
12.11. Vitrolife Ab
12.11.1. Overview
12.11.2. Product Portfolio
12.11.3. Strategic Moves
12.11.4. Scot Analysis
12.12. Thermo Fisher Scientific Inc
12.12.1. Overview
12.12.2. Product Portfolio
12.12.3. Strategic Moves
12.12.4. Scot Analysis
12.13. The Cooper Companies, Inc
12.13.1. Overview
12.13.2. Product Portfolio
12.13.3. Strategic Moves
12.13.4. Scot Analysis
12.14. Quest Diagnostic
12.14.1. Overview
12.14.2. Product Portfolio
12.14.3. Scot Analysis
12.14.4. Strategic Moves
12.15. Esco Micro Pte. Ltd.
12.15.1. Overview
12.15.2. Product Portfolio
12.15.3. Strategic Moves
12.15.4. Scot Analysis
12.16. Elucigene
12.16.1. Overview
12.16.2. Product Portfolio
12.16.3. Scot Analysis
12.16.4. Strategic Initiative
12.17. Alere
12.17.1. Overview
12.17.2. Product Portfolio
12.17.3. Scot Analysis
12.17.4. Strategic Initiative
12.18. Celmatrix
12.18.1. Overview
12.18.2. Product Portfolio
12.18.3. Scot Analysis
12.18.4. Strategic Initiative
12.19. Veritas Genetics
12.19.1. Overview
12.19.2. Product Portfolio
12.19.3. Scot Analysis
12.19.4. Strategic Initiative
12.20. Claritas Genomics
12.20.1. Overview
12.20.2. Product Portfolio
12.20.3. Scot Analysis
12.20.4. Strategic Initiative
12.21. Roche
12.21.1. Overview
12.21.2. Product Portfolio
12.21.3. Scot Analysis
12.21.4. Strategic Initiative
12.22. Labcorp
12.22.1. Overview
12.22.2. Product Portfolio
12.22.3. Scot Analysis
12.22.4. Strategic Initiative
12.23. Agilent
12.23.1. Overview
12.23.2. Product Portfolio
12.23.3. Scot Analysis
12.23.4. Strategic Initiative
12.24. Integrated Genetics
12.24.1. Overview
12.24.2. Product Portfolio
12.24.3. Scot Analysis
12.25. Phosphorus Diagnostics
12.25.1. Overview
12.25.2. Product Portfolio
12.25.3. Scot Analysis
12.25.4. Strategic Initiative
12.26. Centogene
12.26.1. Overview
12.26.2. Product Portfolio
12.26.3. Scot Analysis
12.26.4. Strategic Initiative
12.27. Natera Inc
12.27.1. Overview
12.27.2. Product Portfolio
12.27.3. Scot Analysis
12.27.4. Strategic Initiative
12.28. Illumina Inc
12.28.1. Overview
12.28.2. Product Portfolio
12.28.3. Scot Analysis
12.28.4. Strategic Initiative
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs